Warby Parker Inc.
WRBY · XNYSCIK 1504776fmd_084EF2VQHXY37DE22C233HETD8Manufacturing · Ophthalmic GoodsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 370 | 394 | 541 | 598 | 670 | 771 | 872 |
| Cost of revenue | 147 | 162 | 223 | 257 | 305 | 344 | 401 |
| Gross profit | 223 | 232 | 318 | 341 | 365 | 427 | 471 |
| Selling, general and administrative | 225 | 288 | 461 | 452 | 437 | 457 | 476 |
| Operating income | (2) | (56) | (144) | (111) | (72) | (30) | (5) |
| Other non-operating income (expense) | 2 | (0) | (0) | 1 | 9 | 11 | 8 |
| Income before taxes | 0 | (56) | (144) | (110) | (63) | (20) | 3 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Net income from continuing operations | 0 | (56) | (144) | (110) | (63) | (20) | 2 |
| Net income | 0 | (56) | (144) | (110) | (63) | (20) | 2 |
| Net income to common shareholders | (58) | (56) | (157) | (110) | (63) | (20) | 2 |